USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 16, 2025 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Oct 16, 2025 | LOPT | I | LETTER OF PROTEST EVIDENCE FORWARDED | Loading... |
| Oct 9, 2025 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Sep 9, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 9, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 3, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 11, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 11, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 11, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 11, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 11, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 7, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 7, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 7, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 6, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 6, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 6, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 28, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 9, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 21, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 21, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Providing independent ratings and reviews of other businesses for commercial purposes
First Use Anywhere:
Nov 14, 2024
First Use in Commerce:
Feb 21, 2025
Classification
International Classes
035
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"APPROVED"